Greenwich, CTCIK 18026304 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
94 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Krystal Biotech Inc | 941.1K | $232.01M | 9.8% | −77.8K | Reduced |
| 2 | Celcuity Inc | 1.81M | $180.36M | 7.7% | +629.4K | Added |
| 3 | Novocure Ltd | 8.53M | $110.30M | 4.7% | −1.11M | Reduced |
| 4 | Praxis Precision Medicines I |
| 363.0K |
| $106.98M |
| 4.5% |
| −496.2K |
| Reduced |
| 5 | Tg Therapeutics Inc | 3.14M | $93.58M | 4.0% | −705.4K | Reduced |
| 6 | Dexcom Inc | 1.30M | $86.09M | 3.7% | +1.30M | New |
| 7 | Biomarin Pharmaceutical Inc | 1.32M | $78.45M | 3.3% | +429.7K | Added |
| 8 | Globus Med Inc | 887.0K | $77.44M | 3.3% | +711.0K | Added |
| 9 | Beta Bionics Inc | 2.53M | $77.23M | 3.3% | −1.34M | Reduced |
| 10 | Amicus Therapeutics Inc | 5.21M | $74.15M | 3.1% | +517.3K | Added |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio